IP Library Granted Patent US 12,084,249
Granted Patent B2
US 12,084,249 · App. 17/380,194 · Granted Sep 10, 2024

Packaging and process for the sterile packaging of objects for medical, pharmaceutical or cosmetic applications

Inventors: Patrick Wolf (St. Gallen, CH); Gregor Fritz Deutschle (Idstein, DE); Volker Rupertus (Alzey, DE)
Assignee: SCHOTT PHARMA AG & CO KGAA
B65D77/003B32B7/12B32B27/08B32B27/32B32B27/34B32B27/36B65D65/40B65D77/26G06T7/0002B32B2307/72B32B2439/46
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,084,249
App. No.
17/380,194
Granted
Sep 10, 2024
Kind
B2
Abstract

Packaging for the sterile storage and transport of objects for medical, pharmaceutical or cosmetic applications and a packaging process are provided. The packaging includes at least one bag made of a first and a second web, bonded to one another, a feature thereof being that the first web consists of a selectively permeable nonwoven fabric and that the second web consists of a laminated film with at least three layers, where the first layer is a polymer film arranged on the external side of the bag, the second layer is a lamination adhesive and the third layer is a polymer film arranged on the internal side of the bag. At least one of the layers of the second web includes one or more pigments. In an 8-bit greyscale image, the seal seam, imaged in transmitted light and contrast-standardized, is depicted within a greyscale value range of 50-200.

Claims (33)

1. A process for monitoring a seal seam of a bag for the sterile packaging of objects for medical, pharmaceutical, or cosmetic applications, the process comprising:

generating an image of the seal seam;

processing the image to generate a standardized image such that the seal seam is depicted in a standardized value range;

evaluating the standardized image in respect of inhomogeneities in the values of the seal seam; and

isolating the bag if the evaluating step detects a defect in the seal seam, wherein the isolating step results in bags not being isolated when the seal seam has a strength that is at least 20 N/15 mm measured in accordance with DIN EN 868-5:2009 Annex D.

2. The process of claim 1 , wherein the bag comprises a transparent or translucent layer and a white layer, and wherein the step of generating the image comprises directing a camera system at the white layer.

3. The process of claim 1 , wherein the step of generating the image comprises generating a transmitted-light image.

4. The process of claim 1 , wherein the processing step comprises generating the standardized image as a contrast-standardized image.

5. The process of claim 1 , wherein the processing step comprises generating the standardized image as an 8-bit greyscale image.

6. The process of claim 1 , wherein the processing step depicting the standardized value range as a greyscale value range.

7. The process of claim 2 , wherein the step of generating the image comprises generating a transmitted-light image.

8. A process for monitoring a seal seam of a bag for the sterile packaging of objects for medical, pharmaceutical, or cosmetic applications, the process comprising:

imaging the seal seam by a camera system in transmitted light to generate an 8-bit greyscale image;

contrast-standardizing the 8-bit greyscale image to generate a contrast-standardized 8-bit greyscale image such that the seal seam is depicted in a greyscale range of 50-200; and

evaluating the contrast-standardized 8-bit greyscale image in respect of inhomogeneities in greyscale values of the seal seam, wherein the seal seam exhibits greyscale values which are at least 30 units above greyscale values of a region surrounding the seal seam.

9. The process according to claim 8 , further comprising:

measuring a remission τ vis of the seal seam in accordance with DIN 5033-1:2009-5 in remission mode with 2° observer; and

evaluating the remission τ vis of the seal seam to an acceptable range between 10%-40%.

10. The process according to claim 8 , further comprising isolating the bag if the evaluating step detects a defect in the seal seam.

11. The process according to claim 8 , wherein the seal seam exhibits a homogenous colour.

12. The packaging according to claim 10 , wherein the isolating step results bags not being isolated when the seal seam has a strength that is at least 20 N/15 mm measured in accordance with DIN EN 868-5:2009 Annex D.

13. A process for monitoring a seal seam of a bag for the sterile packaging of objects for medical, pharmaceutical, or cosmetic applications, the process comprising:

imaging the seal seam by a camera system in transmitted light to generate an 8-bit greyscale image;

contrast-standardizing the 8-bit greyscale image to generate a contrast-standardized 8-bit greyscale image such that the seal seam is depicted in a greyscale range of 50-200; and

evaluating the contrast-standardized 8-bit greyscale image in respect of inhomogeneities in greyscale values of the seal seam, wherein the seal seam comprises a bond between a first web and a second web, the first web consisting of a selectively permeable nonwoven fabric and the second web consisting of a laminated film with a first layer, a second layer, and a third layer, the first layer is a polymer film arranged on an external side, the second layer is a lamination adhesive, and the third layer is another polymer film arranged on an internal side, the first layer having a melting point that is above a sealing-initiation temperature of the third layer by at least 20° C.

14. The process according to claim 13 , wherein at least one of the first, second, and third layers comprising a pigment.

15. The process according to claim 13 , wherein the remission τ vis of the seal seam exhibits a difference of 30-75 percentage points to a remission τ vis of the first web measured in accordance with DIN 5033-1:2009-5 in remission mode with 2° observer.

16. A process for monitoring a seal seam of a bag for the sterile packaging of objects for medical, pharmaceutical, or cosmetic applications, the process comprising:

imaging the seal seam by a camera system in transmitted light to generate an 8-bit greyscale image;

contrast-standardizing the 8-bit greyscale image to generate a contrast-standardized 8-bit greyscale image such that the seal seam is depicted in a greyscale range of 50-200; and

evaluating the contrast-standardized 8-bit greyscale image in respect of inhomogeneities in greyscale values of the seal seam, wherein the step of imaging the seal seam further comprises imaging the seal seam with a tub or tray arranged in the bag.

17. The process according to claim 16 , wherein the tub or tray comprises one or more objects for medical, pharmaceutical or cosmetic applications arranged in the tub or tray.

18. The process according to claim 16 , wherein the tub or tray comprises a protective covering of another selectively permeable nonwoven fabric sealed or adhesive bonded thereto.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 21, 2022
From: SCHOTT AG
To: SCHOTT PHARMA AG & CO. KGAA
Reel/Frame 061972/0280 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 20, 2021
From: WOLF, PATRICK; DEUTSCHLE, GREGOR FRITZ; RUPERTUS, VOLKER, DR
To: SCHOTT AG
Reel/Frame 056911/0787 →
Priority Claims (1)
EP 19183002 · Jun 27, 2019 · regional
Continuity (2)
Division 16731644 · Dec 31, 2019
Related Publication 20210347548A1 · Nov 11, 2021